Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
66581
Increased apoptosis, gliosis, mitochondria dysfunction and gliocentric cell fate shift in DS HNPs.
Published 2011“…(B) The increase in programmed progenitor cell death seen <i>in vivo</i> is also appreciated <i>in vitro</i> in human DS neurospheres after one week of culture. …”
-
66582
-
66583
-
66584
-
66585
-
66586
-
66587
Video_3_Mapping of the supplementary motor area using repetitive navigated transcranial magnetic stimulation.MP4
Published 2023“…Further, the lower extremity was mapped at 20 Hz (140%RMT) using a toe tapping task.</p>Results<p>Mean finger tapping scores decreased significantly during stimulation (25.70taps) compared to baseline (30.48; p < 0.01). …”
-
66588
Video_2_Mapping of the supplementary motor area using repetitive navigated transcranial magnetic stimulation.MP4
Published 2023“…Further, the lower extremity was mapped at 20 Hz (140%RMT) using a toe tapping task.</p>Results<p>Mean finger tapping scores decreased significantly during stimulation (25.70taps) compared to baseline (30.48; p < 0.01). …”
-
66589
-
66590
-
66591
-
66592
-
66593
-
66594
-
66595
-
66596
-
66597
Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG
Published 2023“…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
-
66598
Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG
Published 2023“…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
-
66599
Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG
Published 2023“…Both topical (RR 0.19, 95% CI 0.08–0.45, P < 0.001) and subconjunctival anti-VEGF agents (RR 0.64, 95% CI 0.45–0.91, P = 0.01) had a positive influence on recurrence. There was no statistically significant difference in complications between the groups (RR 0.80, 95% CI 0.52–1.22, P = 0.29).…”
-
66600